Autologous Cord Blood Cells for Prevention of BPD in Preterm

Status:
Completed

Trial end date:
2020-01-01

Target enrollment:

Participant gender:

To study the effect of Autologous cord blood cells infusion on prevention of bronchopulmonary dysplasia in very preterm neonates

Phase 2

yangjie